Formulation And Evaluation Of Ordoispersible Tablet Of Frovatriptan

Authors

  • Dr.G.Chinnadevi -Guide Author
  • J Keerthana Author

Keywords:

Frovatriptan, Ordoispersible Tablet

Abstract

The necessity for easy dosage techniques has increased during the last two decades. Because of this, the
pharmaceutical wholesale sector has expanded by over 350 firms, while the medical devices sector has
expanded by over 1,000. The value of the market for these goods is projected to reach $60 billion by 2005, up
from $14.20 billion in 1995.When considering patient compliance, usability, safety, and the capacity to
accommodate a broad range of pharmacological options, oral administration is preferable (1, 2). Manufacturing
expenses are reduced for inert oral delivery systems since sterile processing is not required. New oral delivery
systems have emerged in recent years in an effort to boost drug adherence. These methods think about the
pharmacological and chemical properties of drugs. Recent developments in technology have made computeraided 3D printing (3DP) of tablets and electrostatic deposition and coating of pharmaceuticals possible. Fastdissolving drug-delivery devices have been an option for children and the elderly who have difficulty
swallowing pills, capsules, and syrups since the late 1970s. rapid dissolving pills, rapid dissolve tablets, and
quick melt tablets all refer to the same kind of medicine. The different dosing strategies are equivalent in theory
and practice. Some solid oral dosage forms are intended to dissolve quickly in the mouth to facilitate quicker
absorption. Pills and capsules might be difficult for the elderly to swallow because of dysphagia. Dysphagia is
linked to conditions such as HIV/AIDS, thyroid ectopy, cerebral palsy, and radiation therapy to the head and
neck

Downloads

Published

21-06-2023

How to Cite

Formulation And Evaluation Of Ordoispersible Tablet Of Frovatriptan. (2023). Indo-American Journal of Pharma and Bio Sciences, 21(2), 17-26. https://iajpb.org/index.php/iajpb/article/view/147